Skip to main content

Proteolytic Enzymes in the Treatment of Malignant Pleural Effusions and Solid Metastases

  • Chapter
Chemotherapy

Part of the book series: Chemotherapy ((CT,volume 8))

  • 116 Accesses

Abstract

In the last decades, a change in the etiology of pleural effusions has occurred. At the present, more than 40 per cent of these are based on malignant disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Kokron, O., Micksche, M., Cerni, C., Titscher, R., Wrba, H. (1976). Proteolytic Enzymes in the Treatment of Malignant Pleural Effusions and Solid Metastases. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Chemotherapy, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4352-3_81

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4352-3_81

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4354-7

  • Online ISBN: 978-1-4613-4352-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics